Literature DB >> 384010

Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management: a review.

J Seidenfeld, L J Marton.   

Abstract

The concept of tumor markers was reviewed, and the potential uses of markers of central nervous system (CNS) tumors and methods for their evaluation were discussed. Markers examined included lactate dehydrogenase, aspartate aminotransferase, fructose-bisphosphate aldolase, the polyamines, desmosterol, and several other enzymatic, nonenzymatic, and immunologic markers. Data collated from the clinical studies surveyed showed isocitrate dehydrogenase, desmosterol, and the polyamines to have the greatest potential utility in the diagnosis of CNS tumors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384010

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Aldolase C/zebrin II is released to the extracellular space after stroke and inhibits the network activity of cortical neurons.

Authors:  Stephanie Linke; Philipp Goertz; Stephan L Baader; Volkmar Gieselmann; Mario Siebler; Ulrich Junghans; Joachim Kappler
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

2.  Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change.

Authors:  J A Royds; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

Review 3.  Malignancy markers in the cerebrospinal fluid.

Authors:  M Koskiniemi
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis.

Authors:  Sung Jin Kang; Kwang Soo Kim; Yoon Suk Ha; So Young Huh; Ji Hyun Lee; Jong Kuk Kim; Min Jeong Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

5.  Red blood cell polyamines as a diagnostic indicator of glioma presence and recurrence.

Authors:  P Elworthy; E Hitchcock
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

6.  Deoxythymidine-kinase in cerebrospinal fluid: a new potential "marker" for brain tumours.

Authors:  J S Gronowitz; C F Källander; H Hagberg; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

7.  Somatomedins in tumour cyst fluid, cerebrospinal fluid, and tumour cytosol in patients with glial tumours.

Authors:  P Prisell; L Persson; J Boethius; V Sara
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

8.  Elevated levels of free putrescine and N1-acetylspermidine in cyst fluids of malignant brain tumours.

Authors:  H Yamazaki; T Tsukahara; J Uki; S Matsuzaki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

9.  Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value.

Authors:  U Herrlinger; H Wiendl; M Renninger; H Förschler; J Dichgans; M Weller
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.